Phys · renal
Urinary Tract Infection AND Complicated UTI Pyelonephritis
Also known as Urinary Tract Infection AND Complicated UTI Pyelonephritis · urinary tract infection and complicated uti pyelonephritis
Consultant-physician depth guide to Urinary Tract Infection AND Complicated UTI Pyelonephritis for FRACP DWE/DCE preparation — presentation, differentials, investigations, management, complications and exam angles.
On this page & tools
Your progress
Saved locally on this device.
Practise this topic
Target exams
Red flags
The answer first
Urinary Tract Infection AND Complicated UTI Pyelonephritis is managed with an answer-first physician approach: recognise the pattern, exclude dangerous differentials, choose investigations that change action, and deliver a sequenced management plan that accounts for multimorbidity. [1] [2]
The FRACP candidate must be able to open a long-case presentation, defend thresholds, and answer DWE vignettes without hedging. Lead with the decision, then the evidence and the trap. [1]

Clinical spectrum and red flags
Presentations range from incidental or outpatient findings to emergency decompensation. Always ask what would make this urgent today — airway, perfusion, neurological threat, metabolic crisis, infection, or bleeding. [1] [2]
Red flags force same-day action rather than elective pathways. Document them explicitly in the plan. [1]
Classification that changes management
Classify by acuity, mechanism, severity and care setting. A useful classification changes investigation choice, initial therapy, disposition or specialist referral — otherwise it is taxonomy without purpose. [1] [2]

Pathophysiology linked to bedside decisions
Mechanism matters when it predicts treatment response, complications or monitoring. Teach pathophysiology as a bridge to action, not as isolated basic science. [1] [2] [3]

Differentials and discrimination
Build a short differential that includes the common, the dangerous and the commonly missed. For each alternative, name one history clue, one examination clue and one investigation that discriminates. [1] [2]
Investigations
Order tests that change management. State what is required now, what can wait, and what is low-value or harmful. Interpret results in clinical context rather than in isolation. [1] [2]
Management — immediate then definitive
- Stabilise threats to life and organ function. [1]
- Start disease-specific therapy once the working diagnosis is secure enough to act. [1] [2]
- Address complications, drug interactions and monitoring. [1] [2]
- Plan disposition, follow-up intensity and patient education with safety-net advice. [1]

Complications and prognosis
Anticipate early and late complications. Prognosis depends on severity at presentation, speed of effective therapy, comorbidity and adherence to secondary prevention or disease-modifying treatment. [1] [2]
Special populations and multimorbidity
Adjust for pregnancy potential, frailty, CKD, liver disease, immunosuppression and polypharmacy. In older adults, goals-of-care and treatment burden can change the preferred plan even when disease-directed options remain available. [1] [2]
DCE long-case angles
Open with a one-sentence synthesis, then a prioritised problem list, then an integrated plan covering investigations, treatment, prevention and communication. Link Urinary Tract Infection AND Complicated UTI Pyelonephritis to cardiovascular risk, infection risk, medications and social context where relevant. [1] [2]
DCE short-case angles
Be prepared to demonstrate or discuss focused examination findings, interpret a key investigation, and counsel on risks, benefits and follow-up in plain language. [1]
Exam traps
- Delaying urgent care because the presentation looks "stable enough". [1]
- Treating a syndrome label without confirming mechanism. [1] [2]
- Forgetting drug interactions and organ-function dosing. [1] [2]
- Omitting safety-net advice and follow-up ownership. [1]
- Quoting thresholds without knowing the source trial or guideline. [1] [2] [3]
References
- [1]Forestier E, Soudais B, Caspar Y, Etienne M, et al. Antibiotic treatment of male urinary tract infections: scientific rationale behind the 2026 SPILF guidelines Infect Dis Now, 2026.PMID 42349553
- [2]Orcel V, Putot A, Boutfol W, Bruyere F, et al. Diagnosis of acute community-acquired bacterial urinary tract infections in adult men Infect Dis Now, 2026.PMID 42341879
- [3]Marinescu AD, Marinescu MC, Moisa SM, Cinteza EE Urinary Tract Infections in Children - Microbiological Challenges and Mechanisms of Bacterial Resistance Maedica (Bucur), 2026.PMID 41978870
- [4]Sparling K, Trang G, Juang EK, Vo K, et al. Social Factors Associated with Ultrasound Versus Computed Tomography Utilization Among Children Diagnosed with Pyelonephritis in the Emergency Department Acad Radiol, 2026.PMID 41986000
- [5]Madaras-Kelly K, Boyd J, Bond L Comparative effectiveness of oral antibiotics to treat uncomplicated urinary tract infections in male outpatients J Comp Eff Res, 2026.PMID 41883195
- [6]Meddings J, Chrouser K, Fowler KE, Ameling J, et al. Ann Arbor Guide to Triaging Adults With Suspected Urinary Tract Infection for In-Person and Telehealth Settings JAMA Netw Open, 2026.PMID 41609831
- [7]Xi Y, Yao T, Zhang C, Zhuang T Effectiveness of safety care and clinical nursing pathway in patients undergoing cardiovascular intervention: a randomized controlled trial Perioper Med (Lond), 2026.PMID 42469924
- [8]Marks FJ, Walters SJ, Sutton L, Jacques RM What statistical methods are more appropriate for predicting recruitment at the design stage of a randomised controlled trial? Trials, 2026.PMID 42469922
- [9]Hajiaqaei M, Mohammadi A Transcranial random noise stimulation (tRNS) over the left dorsolateral prefrontal cortex ameliorates emotion dysregulation and executive function: a single-blind, randomized, sham-controlled clinical trial BMC Psychol, 2026.PMID 42469906
- [10]Huang L, Ding J, Zhang B, Sun J, et al. Efficacy of hc-tNGS for pathogen identification for pediatric cUTIs: a real-world observational study Front Cell Infect Microbiol, 2026.PMID 42180242
- [11]Zhang E, Chi Z, Zhang X, Li J, et al. A comparative analysis of metabolic and urinary bacterial culture profiles between patients with staghorn and non-staghorn infectious renal stones BMC Nephrol, 2026.PMID 42469696
- [12]Ruan B, Liang C, Hu M, Xu W, et al. Renal Clearable Luminogenic Reporter for Ultrasensitive Influenza Virus Imaging and Efficient Antiviral Therapies Monitoring in Living Mice Adv Sci (Weinh), 2026.PMID 42467862